Spots Global Cancer Trial Database for pralatrexate injection
Every month we try and update this database with for pralatrexate injection cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Pralatrexate vs Observation Following CHOP-based Chemotherapy in Undiagnosed Peripheral T-cell Lymphoma Patients | NCT01420679 | Peripheral T-ce... | Pralatrexate In... | 18 Years - | Spectrum Pharmaceuticals, Inc | |
Study of Pralatrexate With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma | NCT00364923 | Peripheral T-ce... | Pralatrexate In... | 18 Years - | Acrotech Biopharma Inc. | |
Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder | NCT00722553 | Carcinoma, Tran... Bladder Cancer Bladder Neoplas... | Pralatrexate In... Vitamin B12 Folic Acid | 18 Years - | Acrotech Biopharma Inc. | |
Study of Pralatrexate With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma | NCT00364923 | Peripheral T-ce... | Pralatrexate In... | 18 Years - | Acrotech Biopharma Inc. | |
A Dose-Finding Study of Folotyn® (Pralatrexate Injection) Plus CHOP With Peripheral T-Cell Lymphoma (PTCL) | NCT02594267 | Peripheral T-Ce... | Pralatrexate In... | 18 Years - | Acrotech Biopharma Inc. | |
To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL | NCT06072131 | Peripheral T Ce... | Belinostat Inje... Pralatrexate In... CHOP COP | 18 Years - | Acrotech Biopharma Inc. | |
Pralatrexate vs Observation Following CHOP-based Chemotherapy in Undiagnosed Peripheral T-cell Lymphoma Patients | NCT01420679 | Peripheral T-ce... | Pralatrexate In... | 18 Years - | Spectrum Pharmaceuticals, Inc | |
A Dose-Finding Study of Folotyn® (Pralatrexate Injection) Plus CHOP With Peripheral T-Cell Lymphoma (PTCL) | NCT02594267 | Peripheral T-Ce... | Pralatrexate In... | 18 Years - | Acrotech Biopharma Inc. | |
A Dose-Finding Study of Folotyn® (Pralatrexate Injection) Plus CHOP With Peripheral T-Cell Lymphoma (PTCL) | NCT02594267 | Peripheral T-Ce... | Pralatrexate In... | 18 Years - | Acrotech Biopharma Inc. | |
Phase I/II Clinical Study of Pralatrexate in Japanese Patients With Relapsed or Refractory Peripheral T-cell Lymphoma | NCT02013362 | Peripheral T-ce... | Pralatrexate in... Vitamin B12 Folic Acid | 20 Years - | Mundipharma K.K. | |
Study of Pralatrexate With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma | NCT00364923 | Peripheral T-ce... | Pralatrexate In... | 18 Years - | Acrotech Biopharma Inc. | |
Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder | NCT00722553 | Carcinoma, Tran... Bladder Cancer Bladder Neoplas... | Pralatrexate In... Vitamin B12 Folic Acid | 18 Years - | Acrotech Biopharma Inc. |